ScholarWorks@Korea University College of Medicine: Ji, Jong Dae

Detailed Information

Ji, Jong Dae (지종대)

Anam Hospital (Department of Rheumatology, Anam Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Metaanalysis:41||Polymorphism:38||Rheumatoid arthritis:27||metaanalysis:21||Systemic lupus erythematosus:13||polymorphism:13||rheumatoid arthritis:12||systemic lupus erythematosus:12||Inflammation:5||Osteoarthritis:5||Macrophages:5||Microarray:5||polymorphisms:5||Osteoclast:4||TREM1:4||Vitamin D receptor:4||Pathwaybased analysis:4||vasculitis:4||linkage:4||genome scan:3||Genomewide association study:3||lupus nephritis:3||Autoimmune diseases:3||responsiveness:3||Bone mineral density:3||spondyloarthropathy:3||osteoarthritis:3||Ankylosing spondylitis:3||Behcet's disease:3||Protein tyrosine phosphatase nonreceptor 22:3||Autoimmunity:3||Psoriasis:3||CELLS:3||Gout:3||INFLAMMATION:2||Vasculitis:2||Wegener granulomatosis:2||Metabolic syndrome:2||MicroRNA:2||adjusted indirect comparison:2||angiotensinconverting enzyme:2||Signal transduction:2||Monocytes:2||arylhydrocarbon receptor:2||CTLA4:2||Multiple sclerosis:2||bone mineral density:2||bone remodeling:2||Network analysis:2||Lymphoma:2||ANCA:2||CYTOKINES:2||gout:2||hyperuricemia:2||RANK:2||interleukin6:2||TNFalpha:2||TNFalpha inhibitors:2||Asthma:2||Ethnicity:2||matrix metalloproteinase1:2||metaanalysis:2||miR146a:2||microRNA:2||monocyte chemoattractant protein1 polymorphisms:2||Interleukin10:2||Celecoxib:2||osteoclastogenesis:2||osteoporosis:2||p53:2||Interleukin23R:2||SLE:2||IL6:2||scleroderma:2||INVIVO:2||susceptibility:2||GSTM1:1||GSTT1:1||GSTs:1||Gene:1||Gene frequency:1||Genetic polymorphism:1||Genomewide association studies:1||Genotype:1||Glucosamine:1||HETEROGENEITY:1||HRQoL:1||Hyperuricemia:1||IFNgamma:1||IL1 beta:1||IL1 receptor antagonist polymorphism:1||IL10:1||IL18:1||INTERLEUKIN1:1||INTERLEUKIN10:1||IVC thrombosis:1||Immune deposition:1||Immune modulation:1||Immune response:1||Immune system:1||Immunoglobulin A (IgA):1||Inflammatory cytokine:1||Insulin resistance:1||Interferon regulatory factor 5:1||Interleukin 10:1||Interleukin18:1||Interleukin6:1||Ischemic colitis:1||JakStat:1||LATVIAN PATIENTS:1||LRP5:1||Leflunomide:1||Literature review:1||Lung:1||Lupus:1||Lupus erythematosus, systemic:1||MCSF:1||MACROPHAGES:1||MAMMALIAN TARGET:1||MCP1:1||MECHANISMS:1||MEDLINE:1||METAANALYSIS:1||MOLIMMUNO:1||MONOCYTES:1||MTHFR:1||Macrophage:1||Malignancy:1||Mannosebinding lectin:1||Mannosebinding lectin gene:1||Metaanalysis:1||Monocytes/macrophages:1||NFκB:1||Naproxen:1||Neuropilin:1||Neuropilins:1||Nocardia asteroides:1||OSTEOCLAST:1||OSTEOCLASTS:1||Obesity, abdominal:1||Osteoclastogenesis:1||Osteoprotegerin:1||PADI4:1||PATHWAY:1||PDCD1:1||PDGFBETARECEPTOR:1||PENTOSIDINE:1||POLYMORPHISM:1||PPAR gamma:1||PPARγ:1||PTPN22:1||Paraoxonase:1||Periodontitis:1||Phosphatidic acid:1||Phox homology domain containing serine/threonine kinase:1||Plexin:1||Plexins:1||Polygammaglutamic acid (gammaPGA):1||Polymorphisms:1||Proctitis:1||Promoter regions, genetic:1||Prostaglandin D2 receptor:1||Prostaglandin E2:1||Protein S activity:1||Pulmonary artery aneurysm:1||Pulmonary embolism:1||Pyoderma gangrenosum:1||RAND technique:1||RAND법:1||RANKL:1||RAPAMYCIN:1||REGION:1||RHEUMATOID ARTHRITIS:1||RPL:1||Renal insufficiency, chronic:1||Response:1||Rheumatic diseases:1||SLC2A9:1||STAT6:1||STAT3:1||STAT4:1||SURVIVAL:1||SYNOVIALFLUID:1||SYNOVIUM:1||SYSTEM:1||SYSTEMICLUPUSERYTHEMATOSUS:1||Safety:1||Scleroderma:1||Semaphorin:1||Semaphorins:1||Sjögren’s syndrome:1||Skin Manifestations:1||Smad1:1||Smad3:1||Stat1 protein:1||Stat3 protein:1||Sweet’s syndrome:1||Synovial macrophages:1||Synovial osteoclast precursors:1||Synovium:1||Systemic lupus:1||Systemic sclerosis:1||TGFbeta:1||TLR:1||TNF blockers:1||TNF inhibitors:1||TNFalpha polymorphism:1||TNFalpha308 polymorphism:1||TNFR2:1||TRAIL:1||TRANSCRIPTION:1||TRANSCRIPTION FACTORS:1||Telomere:1||Thyroid cancer:1||Tolllike receptor:1||Toxic epidermal necrolysis:1||Trimethoprim/sulfamethoxazole:1||Tumor necrosis factor:1||Tumor necrosis factor alpha inducible protein 3:1||Tyrosine kinase 2:1||VARIANT:1||VNTR:1||Variant alleles:1||Wegener's granulomatosis:1||acetaminophen:1||actinomycinD:1||ankylosing spondylitis:1||ankylosis:1||aortitis:1||apoptosis:1||autoimmune diseases:1||beta(2)glycoprotein I:1||beta3 adrenergic receptor:1||cardiovascular risk:1||clinical practice guidelines:1||connective tissue disease:1||corticosteroid:1||cyclophosphamide:1||cytochrome P450:1||eNOS:1||erythematosus:1||formal consensus method:1||fracture:1||inflammation mediators:1||insulin resistance:1||kynurenine:1||length:1||low bone mineral density:1||lymphocytes:1||mTOR:1||mTORCEBP/β:1||metabolic syndrome X:1||monocytes/macrophages:1||mortality:1||mycophenolate mofetil:1||osteoclast:1||psoriasis:1||pulmonary hypertension:1||randomized controlled trial:1||relapsing polychondritis:1||rheumatism:1||risk factors:1||survival:1||synovial fibroblast:1||systematic review:1||systemic sclerosis:1||tacrolimus:1||tolllike receptor:1||tramadol:1||tumor necrosis factoralpha:1||골관절염:1||공식적 합의 방법론:1||임상 진료 지침:1||전신홍반루푸스:1||직장 궤양:1||1:1||허혈성 장염:1||1 alpha,25dihydroxyviamin D3:1||1,25(OH)2D3:1||1,25Dihydroxyviamin D3:1||1,25Dihydroxyviamin D3:1||1,25Dihydroxyvitamin D3:1||1,25dihydroxyvitamin D3:1||15dPGJ(2):1||25(OH)2D3:1||5deoxydelta(12,14)prostaglandin J(2):1||ADAPTER PROTEINS:1||ALPHA:1||ALVEOLAR BONE LOSS:1||ANALOGS:1||ARTHRITIS:1||AUTOIMMUNE:1||AUTOIMMUNEDISEASES:1||Amyotrophic lateral sclerosis:1||Angioedema:1||Angiotensinconverting enzyme:1||AntiLa/SSB antibody:1||AntiRo/SSA antibody:1||AntiTNF:1||Antiphospholipid syndrome:1||Antineutrophil cytoplasmic antibody associated vasculitis:1||Antiphospholipid antibodies:1||Antiphospholipid antibody syndrome:1||Apoptosis:1||Associated vasculitis:1||Axial spondyloarthritis:1||BONE LOSS:1||Bee venoms:1||Bile acid receptor:1||Bioinformatics:1||CFOS:1||CFms:1||CD226:1||CD40:1||COLLAGEN:1||COXIBS:1||CTLA4 polymorphisms:1||CUTTING EDGE:1||CYP24:1||Calcium channel:1||Cancer:1||Candidate gene:1||Central nervous system involvement:1||Chondroitin:1||Cogan's syndrome:1||Complement system proteins:1||Conjunctiva:1||Copy number variation:1||Cytokines:1||Cytotoxic T lymphocyte antigen4:1||DISEASE:1||DISEASES:1||DISH:1||Deep vein thrombosis:1||Differentiation:1||ERAP1:1||EVEROLIMUS:1||EXPRESSION:1||Efficacy:1||Endothelial nitric oxide synthase:1||Endovascular embolization:1||Etoricoxib:1||FAMILIES:1||FAS:1||FC gamma RECEPTOR:1||FCGR polymorphism:1||FCGR3B:1||FCRL3:1||Fc receptor:1||Fibromyalgia:1||GENE:1||GENEEXPRESSION:1||

STATISTICS: Total View :12,656,946; Today View :3,134

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE